FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
A study found increases in collagen, elastin, and other extracellular matrix proteins following Radiesse treatment, along with improvements in markers of solar elastosis, a sign of sun-damaged skin.